Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results
Provided By GlobeNewswire
Last update: Feb 25, 2025
SUNNYVALE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today reported financial results for the fourth quarter and full year ended December 31, 2024.
Read more at globenewswire.com
